Skip to main content

Closed

CHRS: Coherus Oncology, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

33thpctl

Volume

0.42×avg

Market Cap

172.60MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Coherus Oncology, Inc.

CHRSNASDAQ Global Market·USD·Closed

Coherus Oncology, Inc.

CHRSNASDAQ·USD·Closed

$1.41

−4.08%

$1.41

−$0.06 (4.08%)

52W Range

33thpctl

Volume

0.42×avg

Mkt Cap

172.60MUSD

P/E

-1.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings